Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)108-115
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume106
Issue number1
DOIs
Publication statusPublished - 2020

Cite this